USA Intravenous Immunoglobulin (IVIg) Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Intravenous immunoglobulin refers to the globulin which is specially prepared for intravenous infusion by precipitation and reprocessing of the components extracted from the plasma of healthy people by low-temperature ethanol method to remove the anti-complement activity and inactivate virus by Pasteurization.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Intravenous Immunoglobulin (IVIg) market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Intravenous Immunoglobulin (IVIg) market. Detailed analysis of key players, along with key growth strategies adopted by Intravenous Immunoglobulin (IVIg) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Hualan Biological Engineering Inc

    • CSL Behring

    • Grifols

    • Kedrion Biopharma Inc

    • Octapharma

    • Baxter International Inc

    • Shanghai RAAS Blood Products Co Ltd

    • LFB group

    • ADMA Biologics, Inc

    • Takeda Pharmaceuticals

    • China Biologics Products, Inc

    By Type:

    • IVIg Liquid

    • IVIg Powder

    By End-User:

    • Immunodeficiency

    • Autoimmune Disease

    • Acute Infection

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Intravenous Immunoglobulin (IVIg) Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Liquid from 2016 to 2027

      • 1.3.2 USA Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Powder from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Immunodeficiency from 2016 to 2027

      • 1.4.2 USA Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Autoimmune Disease from 2016 to 2027

      • 1.4.3 USA Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Acute Infection from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Intravenous Immunoglobulin (IVIg) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Intravenous Immunoglobulin (IVIg) by Major Types

      • 3.4.1 Market Size and Growth Rate of IVIg Liquid

      • 3.4.2 Market Size and Growth Rate of IVIg Powder

    4 Segmentation of Intravenous Immunoglobulin (IVIg) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Intravenous Immunoglobulin (IVIg) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Intravenous Immunoglobulin (IVIg) in Immunodeficiency

      • 4.4.2 Market Size and Growth Rate of Intravenous Immunoglobulin (IVIg) in Autoimmune Disease

      • 4.4.3 Market Size and Growth Rate of Intravenous Immunoglobulin (IVIg) in Acute Infection

    5 Market Analysis by Regions

    • 5.1 USA Intravenous Immunoglobulin (IVIg) Production Analysis by Regions

    • 5.2 USA Intravenous Immunoglobulin (IVIg) Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 6.1 West USA Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 6.2 West USA Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    7 South USA Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 7.1 South USA Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 7.2 South USA Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    8 Middle West USA Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 8.1 Middle West USA Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 8.2 Middle West USA Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    9 Northeast USA Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 9.1 Northeast USA Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 9.2 Northeast USA Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Hualan Biological Engineering Inc

        • 10.1.1 Hualan Biological Engineering Inc Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 CSL Behring

        • 10.2.1 CSL Behring Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Grifols

        • 10.3.1 Grifols Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Kedrion Biopharma Inc

        • 10.4.1 Kedrion Biopharma Inc Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Octapharma

        • 10.5.1 Octapharma Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Baxter International Inc

        • 10.6.1 Baxter International Inc Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Shanghai RAAS Blood Products Co Ltd

        • 10.7.1 Shanghai RAAS Blood Products Co Ltd Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 LFB group

        • 10.8.1 LFB group Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 ADMA Biologics, Inc

        • 10.9.1 ADMA Biologics, Inc Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Takeda Pharmaceuticals

        • 10.10.1 Takeda Pharmaceuticals Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 China Biologics Products, Inc

        • 10.11.1 China Biologics Products, Inc Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Liquid from 2016 to 2027

    • Figure USA Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Powder from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Immunodeficiency from 2016 to 2027

    • Figure USA Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Autoimmune Disease from 2016 to 2027

    • Figure USA Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Acute Infection from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Intravenous Immunoglobulin (IVIg) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Intravenous Immunoglobulin (IVIg)

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Intravenous Immunoglobulin (IVIg) by Different Types from 2016 to 2027

    • Table Consumption Share of Intravenous Immunoglobulin (IVIg) by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of IVIg Liquid

    • Figure Market Size and Growth Rate of IVIg Powder

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Intravenous Immunoglobulin (IVIg) by Different End-Users from 2016 to 2027

    • Table Consumption Share of Intravenous Immunoglobulin (IVIg) by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Immunodeficiency

    • Figure Market Size and Growth Rate of Autoimmune Disease

    • Figure Market Size and Growth Rate of Acute Infection

    • Table USA Intravenous Immunoglobulin (IVIg) Production by Regions

    • Table USA Intravenous Immunoglobulin (IVIg) Production Share by Regions

    • Figure USA Intravenous Immunoglobulin (IVIg) Production Share by Regions in 2016

    • Figure USA Intravenous Immunoglobulin (IVIg) Production Share by Regions in 2021

    • Figure USA Intravenous Immunoglobulin (IVIg) Production Share by Regions in 2027

    • Table USA Intravenous Immunoglobulin (IVIg) Consumption by Regions

    • Table USA Intravenous Immunoglobulin (IVIg) Consumption Share by Regions

    • Figure USA Intravenous Immunoglobulin (IVIg) Consumption Share by Regions in 2016

    • Figure USA Intravenous Immunoglobulin (IVIg) Consumption Share by Regions in 2021

    • Figure USA Intravenous Immunoglobulin (IVIg) Consumption Share by Regions in 2027

    • Table West USA Intravenous Immunoglobulin (IVIg) Consumption by Types from 2016 to 2027

    • Table West USA Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2016 to 2027

    • Figure West USA Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2016

    • Figure West USA Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2021

    • Figure West USA Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2027

    • Table West USA Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2016 to 2027

    • Table West USA Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2016

    • Figure West USA Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2021

    • Figure West USA Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2027

    • Table South USA Intravenous Immunoglobulin (IVIg) Consumption by Types from 2016 to 2027

    • Table South USA Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2016 to 2027

    • Figure South USA Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2016

    • Figure South USA Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2021

    • Figure South USA Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2027

    • Table South USA Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2016 to 2027

    • Table South USA Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2016

    • Figure South USA Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2021

    • Figure South USA Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2027

    • Table Middle West USA Intravenous Immunoglobulin (IVIg) Consumption by Types from 2016 to 2027

    • Table Middle West USA Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2016

    • Figure Middle West USA Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2021

    • Figure Middle West USA Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2027

    • Table Middle West USA Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2016

    • Figure Middle West USA Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2021

    • Figure Middle West USA Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2027

    • Table Northeast USA Intravenous Immunoglobulin (IVIg) Consumption by Types from 2016 to 2027

    • Table Northeast USA Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2016

    • Figure Northeast USA Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2021

    • Figure Northeast USA Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2027

    • Table Northeast USA Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2016

    • Figure Northeast USA Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2021

    • Figure Northeast USA Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Hualan Biological Engineering Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hualan Biological Engineering Inc

    • Figure Sales and Growth Rate Analysis of Hualan Biological Engineering Inc

    • Figure Revenue and Market Share Analysis of Hualan Biological Engineering Inc

    • Table Product and Service Introduction of Hualan Biological Engineering Inc

    • Table Company Profile and Development Status of CSL Behring

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Behring

    • Figure Sales and Growth Rate Analysis of CSL Behring

    • Figure Revenue and Market Share Analysis of CSL Behring

    • Table Product and Service Introduction of CSL Behring

    • Table Company Profile and Development Status of Grifols

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols

    • Figure Sales and Growth Rate Analysis of Grifols

    • Figure Revenue and Market Share Analysis of Grifols

    • Table Product and Service Introduction of Grifols

    • Table Company Profile and Development Status of Kedrion Biopharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kedrion Biopharma Inc

    • Figure Sales and Growth Rate Analysis of Kedrion Biopharma Inc

    • Figure Revenue and Market Share Analysis of Kedrion Biopharma Inc

    • Table Product and Service Introduction of Kedrion Biopharma Inc

    • Table Company Profile and Development Status of Octapharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Octapharma

    • Figure Sales and Growth Rate Analysis of Octapharma

    • Figure Revenue and Market Share Analysis of Octapharma

    • Table Product and Service Introduction of Octapharma

    • Table Company Profile and Development Status of Baxter International Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter International Inc

    • Figure Sales and Growth Rate Analysis of Baxter International Inc

    • Figure Revenue and Market Share Analysis of Baxter International Inc

    • Table Product and Service Introduction of Baxter International Inc

    • Table Company Profile and Development Status of Shanghai RAAS Blood Products Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai RAAS Blood Products Co Ltd

    • Figure Sales and Growth Rate Analysis of Shanghai RAAS Blood Products Co Ltd

    • Figure Revenue and Market Share Analysis of Shanghai RAAS Blood Products Co Ltd

    • Table Product and Service Introduction of Shanghai RAAS Blood Products Co Ltd

    • Table Company Profile and Development Status of LFB group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LFB group

    • Figure Sales and Growth Rate Analysis of LFB group

    • Figure Revenue and Market Share Analysis of LFB group

    • Table Product and Service Introduction of LFB group

    • Table Company Profile and Development Status of ADMA Biologics, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ADMA Biologics, Inc

    • Figure Sales and Growth Rate Analysis of ADMA Biologics, Inc

    • Figure Revenue and Market Share Analysis of ADMA Biologics, Inc

    • Table Product and Service Introduction of ADMA Biologics, Inc

    • Table Company Profile and Development Status of Takeda Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceuticals

    • Table Product and Service Introduction of Takeda Pharmaceuticals

    • Table Company Profile and Development Status of China Biologics Products, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Biologics Products, Inc

    • Figure Sales and Growth Rate Analysis of China Biologics Products, Inc

    • Figure Revenue and Market Share Analysis of China Biologics Products, Inc

    • Table Product and Service Introduction of China Biologics Products, Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.